AKT1 and cancer: TACC3 inhibitor could reduce sphere formation, clonogenicity, cell growth and proliferation, and cancer stem cell-like phenotype by suppressing the Wnt/β-catenin and PI3K/AKT signaling pathways (Zhou et al., 2015).